STI Prevalence, Incidence, and Costs in the United States: New Estimates, New Approach
- PMID: 33492092
- DOI: 10.1097/OLQ.0000000000001368
STI Prevalence, Incidence, and Costs in the United States: New Estimates, New Approach
Conflict of interest statement
Conflict of Interest and Sources of Funding: None declared.
References
-
- Workowski KA, Bolan GA; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015; 64(RR-03):1–137.
-
- Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2018. Atlanta: U.S. Department of Health and Human Services; 2019. doi:10.15620/cdc.79370.
-
- Markowitz LE, Dunne EF, Saraiya M, et al. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2014; 63(RR-05):1–30.
-
- LeFevre ML; U.S. Preventive Services Task Force. Screening for chlamydia and gonorrhea: U.S. preventive services task force recommendation statement. Ann Intern Med 2014; 161:902–910.
-
- Department of Health and Human Services. Fiscal Year 2018: Centers for Disease Control and Prevention Justification for Estimates for Appropriation Committees. Available at: https://www.cdc.gov/budget/documents/fy2018/fy-2018-cdc-congressional-ju... . Accessed December 8, 2020.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical